Nfocus

Nfocus has developed a biomimetic coating which is covalently bonded to the surface of a device and is designed to promote rapid healing.

The company's first product, The Nfocus Stent Graft received CE mark for use in the treatment of diseased saphenous vein grafts, aneurysms and perforations.

In addition to its unique biomimetic surface, the Nfocus balloon expandable stent graft minimizes trauma by being very flexible, and easy to deploy.

Nfocus was recently formed through the merging of Cardiovasc and Acta.